L
Lena M. Napolitano
Researcher at University of Michigan
Publications - 314
Citations - 20992
Lena M. Napolitano is an academic researcher from University of Michigan. The author has contributed to research in topics: ARDS & Intensive care. The author has an hindex of 62, co-authored 297 publications receiving 17573 citations. Previous affiliations of Lena M. Napolitano include United States Department of Veterans Affairs & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Gender and diversity considerations in surgical training
TL;DR: Some measures that may enhance the value of a surgical career for women are proposed, and in so doing, likely improve the quality of surgical training for all prospective surgeons.
Journal ArticleDOI
Reduction in Venous Thromboembolism Events: Trauma Performance Improvement and Loop Closure Through Participation in a State-Wide Quality Collaborative.
David Machado-Aranda,Jill L. Jakubus,Wendy L. Wahl,Jill R. Cherry-Bukowiec,Kathleen B. To,Pauline K. Park,Krishnan Raghavendran,Lena M. Napolitano,Mark R. Hemmila +8 more
TL;DR: The performance improvement process used to reduce the rate of VTE using MTQIP infrastructure supported execution and monitoring of the action plan consistent with loop-closure practices, and a positive performance improvement result was achieved with VTE reduction.
Journal ArticleDOI
Intestinal epithelial cell regulation of macrophage and lymphocyte interleukin 10 expression
TL;DR: Enterocytes are a responsive source of IL-10 and may play a role in modulating production of this important cytokine by the local inflammatory cells of the gut, suggesting a central role for this cytokine in regulation of the local intestinal inflammatory response.
Journal ArticleDOI
Treatment of Cytokine Storm in COVID-19 Patients With Immunomodulatory Therapy.
Lenar Yessayan,Balazs Szamosfalvi,Lena M. Napolitano,Benjamin H. Singer,Katsuo Kurabayashi,Yujing Song,Angela J. Westover,H. David Humes +7 more
TL;DR: The results observed with SCD therapy on these two critically ill COVID-19 patients with severe ARDS and elevated IL-6 is encouraging and a multicenter clinical trial is underway with a FDA-approved Investigational Device Exemption to evaluate the potential of SCD Therapy to effectively treat CO VID-19 ICU patients.
Journal ArticleDOI
Nontrauma Emergency Surgery: Optimal Case Mix for General Surgery and Acute Care Surgery Training
Jill R. Cherry-Bukowiec,Barbra S. Miller,Gerard M. Doherty,Melissa E. Brunsvold,Mark R. Hemmila,Pauline K. Park,Krishnan Raghavendran,Kristen C. Sihler,Wendy L. Wahl,Stewart C. Wang,Lena M. Napolitano +10 more
TL;DR: In an era of declining operative caseload in trauma, the NTE service provides ample opportunity for complex general surgery decision making and operative procedures for surgical residency education, including advanced surgical critical care management.